Reimbursement Listing and Drug Pricing Strategy Consulting
Considering the reimbursement listing characteristics of medical technologies, pharmaceuticals, and treatment materials, Meditip provides customized consulting across the entire market entry cycle, from economic evaluation and relative value scores to drug pricing and treatment material pricing strategies.
New Health Technology Assessment Application
Based on the safety, efficacy, and cost-effectiveness of new medical technologies, we support the entire listing strategy process, from preparing assessment application materials to evidence analysis.
Key Services
- New Health Technology Assessment Application
- Safety / Efficacy Analysis
- Systematic Review
- Cost-Effectiveness Analysis
Procedure Fee and Relative Value Score Determination
To establish relative value scores and reimbursement criteria for medical procedures, we comprehensively analyze economic feasibility, budget impact, and health insurance benefit criteria.
Key Services
- Procedure Fee Determination Application
- Health Insurance Budget Impact Analysis
- Relative Value Score Determination Application
- Health Insurance Benefit Criteria Analysis
- Cost-Effectiveness Analysis
Drug Pricing Determination Application
We support drug price calculation and listing strategy development that considers the market value and reimbursement strategy of pharmaceuticals.
Key Services
- Drug Pricing Determination Application
- Reimbursement Listing Material Preparation
- Drug Pricing Strategy Development
- Economic Evaluation Material Review
Treatment Material Pricing Determination
We provide strategies based on market value and budget impact for the reimbursement listing and price calculation of treatment materials.
Key Services
- Treatment Material Pricing Determination Application
- Economic / Budget Impact Analysis
- Reimbursement Listing Strategy
- Treatment Material Value Assessment